Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy
Crossref DOI link: https://doi.org/10.1007/s00432-014-1904-z
Published Online: 2014-12-30
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walts, Ann E.
Bomalaski, John S.
Ines, Delma
Orsulic, Sandra
Text and Data Mining valid from 2014-12-30